Review Article Online Publishing Date: | ||||||||||||
IJMDC. 2023; 7(5): 818-821 Safety and efficacy of favipiravir in COVID-19: a comprehensive literature review Khalid M. Ahusayni, Salman A. Alharthi, Mona Y. Alhazmi, Shaima S. Alaithan, Yasir Alotaibi, Zahra A. Alhaddad, Alhanuf A. Alrowaished, Hissah A. Almousa, Abdulaziz A. Hakami, Yasmin B. Alotaibi.
|
How to Cite this Article |
Pubmed Style Ahusayni KM, Alharthi SA, Alhazmi MY, Alaithan SS, Alotaibi Y, Alhaddad ZA, Alrowaished AA, Almousa HA, Hakami AA, Alotaibi YB. Safety and efficacy of favipiravir in COVID-19: a comprehensive literature review. IJMDC. 2023; 7(5): 818-821. doi:10.24911/IJMDC.51-1671556666 Web Style Ahusayni KM, Alharthi SA, Alhazmi MY, Alaithan SS, Alotaibi Y, Alhaddad ZA, Alrowaished AA, Almousa HA, Hakami AA, Alotaibi YB. Safety and efficacy of favipiravir in COVID-19: a comprehensive literature review. https://www.ijmdc.com/?mno=126074 [Access: May 10, 2024]. doi:10.24911/IJMDC.51-1671556666 AMA (American Medical Association) Style Ahusayni KM, Alharthi SA, Alhazmi MY, Alaithan SS, Alotaibi Y, Alhaddad ZA, Alrowaished AA, Almousa HA, Hakami AA, Alotaibi YB. Safety and efficacy of favipiravir in COVID-19: a comprehensive literature review. IJMDC. 2023; 7(5): 818-821. doi:10.24911/IJMDC.51-1671556666 Vancouver/ICMJE Style Ahusayni KM, Alharthi SA, Alhazmi MY, Alaithan SS, Alotaibi Y, Alhaddad ZA, Alrowaished AA, Almousa HA, Hakami AA, Alotaibi YB. Safety and efficacy of favipiravir in COVID-19: a comprehensive literature review. IJMDC. (2023), [cited May 10, 2024]; 7(5): 818-821. doi:10.24911/IJMDC.51-1671556666 Harvard Style Ahusayni, K. M., Alharthi, . S. A., Alhazmi, . M. Y., Alaithan, . S. S., Alotaibi, . Y., Alhaddad, . Z. A., Alrowaished, . A. A., Almousa, . H. A., Hakami, . A. A. & Alotaibi, . Y. B. (2023) Safety and efficacy of favipiravir in COVID-19: a comprehensive literature review. IJMDC, 7 (5), 818-821. doi:10.24911/IJMDC.51-1671556666 Turabian Style Ahusayni, Khalid M., Salman A. Alharthi, Mona Y. Alhazmi, Shaima S. Alaithan, Yasir Alotaibi, Zahra A. Alhaddad, Alhanuf A. Alrowaished, Hissah A. Almousa, Abdulaziz A. Hakami, and Yasmin B. Alotaibi. 2023. Safety and efficacy of favipiravir in COVID-19: a comprehensive literature review. International Journal of Medicine in Developing Countries, 7 (5), 818-821. doi:10.24911/IJMDC.51-1671556666 Chicago Style Ahusayni, Khalid M., Salman A. Alharthi, Mona Y. Alhazmi, Shaima S. Alaithan, Yasir Alotaibi, Zahra A. Alhaddad, Alhanuf A. Alrowaished, Hissah A. Almousa, Abdulaziz A. Hakami, and Yasmin B. Alotaibi. "Safety and efficacy of favipiravir in COVID-19: a comprehensive literature review." International Journal of Medicine in Developing Countries 7 (2023), 818-821. doi:10.24911/IJMDC.51-1671556666 MLA (The Modern Language Association) Style Ahusayni, Khalid M., Salman A. Alharthi, Mona Y. Alhazmi, Shaima S. Alaithan, Yasir Alotaibi, Zahra A. Alhaddad, Alhanuf A. Alrowaished, Hissah A. Almousa, Abdulaziz A. Hakami, and Yasmin B. Alotaibi. "Safety and efficacy of favipiravir in COVID-19: a comprehensive literature review." International Journal of Medicine in Developing Countries 7.5 (2023), 818-821. Print. doi:10.24911/IJMDC.51-1671556666 APA (American Psychological Association) Style Ahusayni, K. M., Alharthi, . S. A., Alhazmi, . M. Y., Alaithan, . S. S., Alotaibi, . Y., Alhaddad, . Z. A., Alrowaished, . A. A., Almousa, . H. A., Hakami, . A. A. & Alotaibi, . Y. B. (2023) Safety and efficacy of favipiravir in COVID-19: a comprehensive literature review. International Journal of Medicine in Developing Countries, 7 (5), 818-821. doi:10.24911/IJMDC.51-1671556666 |